RLS Global is a Swedish MedTech company based in Gothenburg, founded in 1996. Through our advanced and unique Buffered Hypochlorite based Technology Platform we focus on developing products based on Gentle methods for Minimally Invasive Treatment.
Our employees have worked within different global medical technology companies, pioneering new therapies and products for the benefit of the patients. At RLS Global they form the very core of our organization and are a constant source of inspiration as we seek new ways to advance the science of Oral & Wound Care for each and every patient. We always aim to make a difference to patients and their families around the world.
Next phase of the company is now becoming a reality and represents RLS Global’s approach to Wound care. Founded in 1996, RLS Global has today 8 employees with the majority of business and infrastructure in Europe. The company is listed at Nasdaq First North Growth Market since May 17, 2017. Previously it was listed at Aktietorget since May, 2012.